Attention Economy


Monday, February 15, 2021

Economics of Vaccine Manufacturing

'We took a huge risk': the Indian firm making more Covid jabs than anyone
Adar Poonawalla, chief executive of the Serum Institute of India, on vaccines, regulation and what comes next
https://www.theguardian.com/global-development/2021/feb/14/we-took-a-huge-risk-the-indian-firm-making-more-covid-jabs-than-anyone